This content is from: Premium Coatue Finished 2022 With Big Purchases of Some Well-Known Stocks The Tiger Cub aggressively bought shares of 10 stocks that now account for nearly 60 percent of the firm’s U.S. long assets. By Stephen Taub February 16, 2023
This content is from: Portfolio The Morning Brief: Starboard Raises Stake in Drugmaker Perrigo By Stephen Taub November 16, 2016
This content is from: Premium Hedge Fund Titans Bet Big on Drugmaker Shire’s Success John Paulson, Dan Loeb, and other prominent Investors move into an industry in flux. By Bailey McCann December 08, 2016
Sponsored Daiichi To Buy Plexxikon For $805M California-based pharmaceutical company, Plexxikon, will be acquired by Japanese drugmaker, Daiichi Sankyo. March 01, 2011
Sponsored Galenika Gets Serbia Guarantee For €70M Loan Serbia will provide guarantees for a loan of nearly €70 million to state-owned Galenika, the country’s biggest state-run drugmaker. June 23, 2011
This content is from: Premium Inside the Trade: What Bill Ackman Sees in Valeant and Allergan The Pershing Square activist has avoided investing in drugmakers before, but he and Valeant CEO Michael Pearson understand each other By Michael Peltz August 22, 2014
